Co-Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Co-Diagnostics and other ETFs, options, and stocks.

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. 

CEO
Dwight Howard Egan
CEODwight Howard Egan
Employees
115
Employees115
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
115
Employees115

CODX Key Statistics

Market cap
7.65M
Market cap7.65M
Price-Earnings ratio
-0.05
Price-Earnings ratio-0.05
Dividend yield
Dividend yield
Average volume
488.79K
Average volume488.79K
High today
$1.65
High today$1.65
Low today
$1.38
Low today$1.38
Open price
$1.60
Open price$1.60
Volume
374.26K
Volume374.26K
52 Week high
$46.50
52 Week high$46.50
52 Week low
$1.26
52 Week low$1.26

Stock Snapshot

With a market cap of 7.65M, Co-Diagnostics(CODX) trades at $1.42. The stock has a price-to-earnings ratio of -0.05.

As of 2026-08-03, Co-Diagnostics(CODX) stock has fluctuated between $1.38 and $1.65. The current price stands at $1.42, placing the stock +2.8% above today's low and -13.9% off the high.

Co-Diagnostics(CODX) shares are trading with a volume of 374.26K, against a daily average of 488.79K.

During the past year, Co-Diagnostics(CODX) stock moved between $1.26 at its lowest and $46.50 at its peak.

During the past year, Co-Diagnostics(CODX) stock moved between $1.26 at its lowest and $46.50 at its peak.

CODX News

TipRanks 3d
Co-Diagnostics Inducement Agreement for New Warrant Financing

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Benzinga 6d
EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test - Benzinga

...

EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test - Benzinga

People also own

Based on the portfolios of people who own CODX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.